Related references
Note: Only part of the references are listed.Current antiplatelet therapies: Benefits and limitations
Dominick J. Angiolillo et al.
AMERICAN HEART JOURNAL (2008)
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
S. M. Zhang et al.
BRITISH JOURNAL OF CANCER (2008)
Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women
Alana G. Hudson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
Soren Friis et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis
Bahi Takkouche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Residual risk of breast cancer recurrence 5 years after adjuvant therapy
Abenaa M. Brewster et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
NSAID use and breast cancer risk in the VITAL cohort
Ann Ready et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005
Sandra Mangiapane et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study
Gretchen L. Gierach et al.
BREAST CANCER RESEARCH (2008)
Nonsteroidal antiinflammatory drugs and breast cancer risk - The multiethnic cohort
Jasmeet K. Gill et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
NSAIDs and breast cancer recurrence in a prospective cohort study
Marilyn L. Kwan et al.
CANCER CAUSES & CONTROL (2007)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The use of aspirin for primary prevention of colorectal cancer: A systematic review prepared for the US Preventive Services Task Force
Catherine Dube et al.
ANNALS OF INTERNAL MEDICINE (2007)
NSAID use and survival after breast cancer diagnosis in post-menopausal women
Cindy K. Blair et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Aspirin and cancer risk: an updated quantitative review to 2005
Cristina Bosetti et al.
CANCER CAUSES & CONTROL (2006)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments
CT Dang et al.
CLINICAL CANCER RESEARCH (2004)
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models
SR Cole et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the physicians' health study
NR Cook et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Methotrexate and mortality in patients with rheumatoid arthritis:: a prospective study
HK Choi et al.
LANCET (2002)
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
H Bartelink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer
N Kundu et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Marginal structural models to estimate the joint causal effect of nonrandomized treatments
MA Hernán et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2001)
Breast cancer and NSAID use: a meta-analysis
SA Khuder et al.
BRITISH JOURNAL OF CANCER (2001)
Host cyclooxygenase-2 modulates carcinoma growth
CS Williams et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men
MA Hernan et al.
EPIDEMIOLOGY (2000)
Share Paper
